We encourage readers to share some of their practice experience: the neat little tricks that
solve difficult clinical situations. Praxis articles can be submitted online at http://mc …

Since FDA approval of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, attention
has been focused on PrEP implementation. The CDC estimates that 1.2 million US adults …

In their excellent brief article, Marcus et al. have compared “the proportion of PrEP
[preexposure prophylaxis] users and non-PrEP users receiving primary care” 1 (p1418) and …

Until recently there have been few primary care office-based strategies to reduce the
transmission of HIV. In May 2014 the Centers for Disease Control and Prevention published …

Annals Academy of Medicine in at-risk populations. Modelling studies suggest that without
PrEP, HIV incidence is unlikely to decrease substantially. 11 The success of PrEP as a …

Since 2012, use of daily preventive medication, such as pre-exposure prophylactic (PrEP)
therapy, has been recommended as an effective HIV prevention strategy. However, rates of …

Primary care physicians (PCPs) are critical for promoting HIV prevention by prescribing pre-
exposure prophylaxis (PrEP). Yet, there are limited data regarding PCP's preferred …

Background Among health care providers, prescription of HIV pre-exposure prophylaxis
(PrEP) has been low. Little is known specifically about primary care physicians (PCPs) with …

Background: Pre-exposure Prophylaxis (PrEP) is a promising intervention to reduce the risk
of acquiring HIV among high-risk individuals including men who have unprotected sex with …

Figure 1. Timeline of PrEP around the world. approval in the UK. Despite much argument to
the contrary, evidence-based data have shown that, for those at highest risk of infection …